Questions and Answers | M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk: Guidance for Industry(问答|M7(R2)评估和控制药物中的DNA反应性（致突变）杂质以限制潜在致癌风险：行业指南)